Bateman’s laboratory focuses on the causes, diagnosis and future treatments of Alzheimer’s disease (AD). We directly measure the pathology and pathophysiology of AD in humans using multiple techniques. Our group uses a wide variety of assays and techniques from the most basic applications, such as quantitative measurement of stable-isotope labeled peptides, to clinical translational studies in diagnostic and therapeutic biomarkers for AD.

WashU Medicine Bold Pioneer Award

Presented by the Department of Neurology

Recognized early career investigators pushing the boundaries in neurological disease, neuroscience or fundamental aging research.

We’re growing!

The Bateman lab is currently looking for additional team members and has several exciting opportunities for qualified motivated candidates!

2023 Bateman Headshot - Sid Hastings Photographer

Randall J. Bateman, MD

Principal Investigator

Randall J. Bateman, MD, is the Charles F. and Joanne Knight Distinguished Professor of Neurology at Washington University School of Medicine, director of the Dominantly Inherited Alzheimer Network (DIAN) and director of the DIAN Trials Unit (DIAN-TU).

Bateman’s laboratory investigates the causes and methods of diagnosis and treatment of Alzheimer’s disease (AD) utilizing a wide variety of assays and techniques from…

Now accepting applications for WashU Medicine Bold Pioneer Award! (Links to an external site)

Now accepting applications for WashU Medicine Bold Pioneer Award!
The goal of the $10,000 WashU Medicine Bold Pioneer Award is to recognize and encourage early career investigators who have demonstrated bold, pioneering research that is high-risk by virtue of being fundamentally different from standard approaches. The intent is to encourage scientific research investigators to challenge status quo approaches by developing fundamentally different methods, approaches, […]

Donate to the Bateman Alzheimer’s research fund.